We then explored the role of the abnormally expressed m6a-related splicing factors in the regulation of the GAS events and constructed the risk signature of these factors to predict NSCLC prognosis after the gene ontology (GO) and the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis. The gene discussed is METTL3; the disease is non-small cell lung carcinoma.